Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022September 29, 2022 Emyria Nine sites across four states will conduct the phase III clinical trial for Emyria’s EMD-RX5 […]
Epsilon future uncertain as half-year losses climb by 94% by Martin Lane September 1, 2022September 1, 2022
